Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Assets Average (2020 - 2026)

Immatics (IMTX) posted Assets Average of $630.4 million for Q4 2025, up 1.0% sequentially from $624.2 million in Q3 2025, and down 8.49% YoY from $688.9 million in Q4 2024.

Analysis

Immatics (IMTX) Assets Average (2020 - 2026) Analysis & Trends

Immatics has reported Assets Average for 6 years, with the latest figure at $630.4 million in Q4 2025.

  • Quarterly Assets Average fell 8.49% year-over-year to $630.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $630.4 million (down 8.49% YoY) and the FY2025 annual result came in at $694.4 million, up 6.41% from the prior year.
  • Assets Average advanced to $630.4 million in Q4 2025 per IMTX's latest filing, from $624.2 million in the prior quarter.
  • Over five years, Assets Average peaked at $709.4 million in Q1 2025 and troughed at $217.2 million in Q4 2021.
  • A 5-year average of $475.4 million and a median of $443.9 million in 2023 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2021 and 2022: Assets Average tumbled 31.51% in 2021, then surged 78.03% in 2022.
  • Over 5 years, Assets Average stood at $217.2 million in 2021, then soared by 78.03% to $386.7 million in 2022, then surged by 32.54% to $512.4 million in 2023, then soared by 34.44% to $688.9 million in 2024, then declined by 8.49% to $630.4 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods registered $630.4 million, $624.2 million, and $658.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Immatics 1.17 Bn 711.21 Mn - 600.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600.31 Mn
Mar 31, 2026 645.30 Mn
Dec 31, 2025 630.40 Mn
Sep 30, 2025 624.19 Mn
Jun 30, 2025 658.57 Mn
Mar 31, 2025 709.44 Mn
Dec 31, 2024 688.91 Mn
Sep 30, 2024 654.55 Mn
Jun 30, 2024 692.35 Mn
Mar 31, 2024 629.11 Mn
Dec 31, 2023 512.45 Mn
Sep 30, 2023 461.43 Mn
Jun 30, 2023 426.46 Mn
Mar 31, 2023 411.16 Mn
Dec 31, 2022 386.65 Mn
Sep 30, 2022 375.11 Mn
Jun 30, 2022 354.85 Mn
Mar 31, 2022 258.25 Mn
Dec 31, 2021 217.18 Mn
Sep 30, 2021 247.65 Mn